http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105030669-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105030669-B
titleOfInvention A kind of curcumin micelle eye drop and preparation method thereof
abstract The invention discloses a kind of curcumin micelle eye drop, it is main ingredient and preservative, isotonic regulator including curcumin, it is excipient substance characterized by further comprising Polyvinylcaprolactame polyvinyl acetate ethylene glycol copolymer, Dequalinium Chloride is Mitochondrially targeted dressing agent and stabilizer, and curcumin main ingredient and Polyvinylcaprolactame polyvinyl acetate the polyethyleneglycol block copolymer excipient substance mass ratio is 1:12‑1:Between 20, Dequalinium Chloride and Polyvinylcaprolactame polyvinyl acetate the ethylene glycol copolymer excipient substance mass ratio is 1:20‑1:Between 40.Curcumin micelle eye drop prepared by the present invention, administration concentration is up to 5mg/ml, and micella particle diameter is small, and distribution is homogeneous, and medicine stability is good.Administration excitant is not only reduced, absorption of the cornea to medicine is also improved, reduces administration concentration, the biddability extend drug treating time, reduce administration number of times, improving patient, there is good economy.
priorityDate 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID136217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450691418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID136217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426067522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20317181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430895435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447843440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 36.